– InsightRX and Premier Inc. Partner to enable 4,000 hospitals, health systems, and providers to personalize treatment for infectious disease patients.
– The integrated solution aims to decrease serious side effects caused by vancomycin and other antibiotics used to treat infectious diseases.
InsightRX, a provider of precision medicine, and Premier Inc., a healthcare improvement company uniting 4,000 U.S. hospitals and health systems, have joined forces to individualize medication dosing for drugs used to treat infectious disease. The integration of InsightRX’s cloud-based precision dosing platform, InsightRX Nova, with Premier’s clinical surveillance technology, powered by TheraDoc, delivers a comprehensive, easy-to-use solution that helps clinicians individualize antibiotic therapy.
The Growing Need for Precision Antibiotic Dosing
The antibiotics used to treat infectious diseases, such as vancomycin, require careful monitoring and dosing regimens that consider patient-specific factors impacted by the drug’s pharmacokinetics and pharmacodynamics. Administering these medications can be complex and can lead to serious side effects, such as acute kidney injury.
Integration Details
The integrated InsightRX Nova® and solution will help clinicians identify at-risk patients and determine an individualized, effective and safe antimicrobial dose with greater accuracy using quantitative pharmacology models and Bayesian forecasting. It also supports compliance with the upcoming vancomycin dosing and monitoring guidelines jointly published by the American Society of Hospital Pharmacists (ASHP), Infectious Disease Society of America (IDSA), Pediatric Infectious Disease Society (PIDS) and Society of Infectious Disease Pharmacists (SIDP).
Increasing Access to Precision Dosing
“We established this partnership with InsightRX to increase access to precision dosing for more than 1,100 hospitals. Clinicians need access to tools that give them the ability to more effectively dose high risk antimicrobials,” said Michelle Allen, vice president and general manager of clinical solutions at Premier. “We recognize the unique value in InsightRX’s solution. We are confident that this integration will immediately benefit our members, including hospitals, health systems and healthcare providers. We look forward to working with InsightRX to help individualize therapy for infectious diseases and hope to expand our partnership to enable precision dosing across a number of therapeutic areas.”
